Back

Efficacy and safety of new-generation atrial antitachycardia pacing for atrial tachyarrhythmias in patients implanted with a cardiac resynchronization therapy.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Cardiac resynchronisation therapy : selection and implantation Cardiac Resynchronisation Therapy (CRT) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Nobuhiko Ueda

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)

9 More presentations in this session

Presentation thumbnail
Normalization of QRS duration to left ventricular dimension improves patient selection for cardiac resynchronization therapy
Mr A. Zweerink (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
MPP reduces the ventricular arrhythmias burden compared to standard biventricular pacing in CRT patients
Doctor F. Zanon (Rovigo, IT)
Abstract Slides
Presentation thumbnail
Clinical performance of quadripolar left ventricular leads compared to biventricular leads
Doctor J. Erath (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Active fixation lead improves clinical response to cardiac resynchronisation therapy
Presentation thumbnail
LV lead apical position could be the best option in selected CRT patients
Doctor F. Zanon (Rovigo, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Cardiac resynchronisation therapy : selection and implantation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients
thumbnail
Congress Presentation
Device therapy: how to identify responders?
thumbnail
Congress Presentation
Cardiac resynchronisation therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources